Pharma industry reputation settles into ‘new normal’ after goodwill from insulin price drop fades
Pharma’s reputation is settling into a consistent “new normal,” with now 45% of consumers reporting a positive perception of the industry, according to The Harris …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.